(19)
(11) EP 1 326 822 A2

(12)

(88) Date of publication A3:
15.08.2002

(43) Date of publication:
16.07.2003 Bulletin 2003/29

(21) Application number: 01981499.5

(22) Date of filing: 11.10.2001
(51) International Patent Classification (IPC)7C07C 49/17, C07C 49/245, C07C 49/258, C07C 49/185, A61K 31/12, A61K 31/185, A61K 31/21, A61K 31/275, A61K 31/095, A61K 31/33, A61K 31/66, C07C 49/782, C07C 49/215, C07C 49/723, C07C 49/743, C07C 49/747, C07C 49/507, C07C 50/30, C07C 261/04, C07F 9/09, C07F 9/24
(86) International application number:
PCT/US0131/872
(87) International publication number:
WO 0203/0860 (18.04.2002 Gazette 2002/16)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 11.10.2000 US 239232 P

(71) Applicant: Esperion Therapeutics Inc.
Ann Arbor, Michigan 48108 (US)

(72) Inventors:
  • DASSEUX, Jean-Louis, H.
    Brighton, MI 48116 (US)
  • ONICIU, Carmen, Daniela
    Gainesville, FL 32605 (US)

(74) Representative: Jump, Timothy John Simon et al
Venner Shipley & Co.20 Little Britain
London EC1A 7DH
London EC1A 7DH (GB)

   


(54) KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES